FHJTX Mutual Fund

NAV$49.71

Fund Essentials - as of Jan 31, 2026

Net Assets
$3M
Expense Ratio
1.81%
Dividend Yield (Current)
1.12%
Holdings
105
Inception Date
Mar 18, 2014
Fund Family
Fidelity Investments (US)
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+7.58%
1 Year+15.80%
3 Year+15.80%
5 Year+5.26%
10 Year+8.88%

Asset Allocation

Stocks: 97.62%
Cash: 2.38%

Price Chart (6M)

Loading chart data...

Top Holdings

View All →
TickerNameWeight
ASML:ASAsml Holding N.V.5.01%
AZN:LNAstraZeneca PLC3.49%
ROG:SMRoche Holding Ag3.35%
ENR1N:MUSiemens Energy Ag3.01%
SHELShell Plc2.88%
Top 10 Concentration: 29.02%Report Date: Jan 31, 2026
Download all 105 holdings for FHJTX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
1.12%
Frequency
Annually
Latest Distribution
$5.64
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how FHJTX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$49$29/mo
Claim the $29 launch price
First 500 subscribers, then $49/mo. Cancel anytime. From MarketXLS, trusted since 2014.

FHJTX Mutual Fund Overview

FHJTX Mutual Fund (Fidelity Advisor Europe Fund Class C) is managed by Fidelity Investments (US) with $2.8M in net assets. FHJTX expense ratio is 1.81%, holding 105 positions across sectors including Unknown, Financials, Health Care. Inception date: 2014-03-18.

FHJTX performance shows a YTD return of 7.58%. The 1-year return is 15.80% and the 5-year return is 5.26%. FHJTX dividend yield stands at 1.12%, paid annually.

FHJTX top holdings include Asml Holding N.V. (5.0%), AstraZeneca PLC (3.5%), Roche Holding Ag (3.4%), Siemens Energy Ag (3.0%), Shell Plc (2.9%). View all FHJTX holdings, sector breakdown, or dividend history.

FHJTX can be compared against other funds using the overlap calculator or side-by-side comparison tool. FHJTX alternatives are available via the screener, along with tax-loss harvesting opportunities.